Literature DB >> 2793802

Behavioral and cognitive subtypes of ADHD.

G J August, B D Garfinkel.   

Abstract

Attention-deficit hyperactivity symptoms are observed by teachers in 9.2% of a nonreferred elementary school population. Two subtypes of attention-deficit hyperactivity disorder (ADHD), a cognitive form and a behavioral form, are identified. The behavioral subtype includes about 80% of those identified and is characterized by distinct clinical phenomenology of inattention, impulsivity, and hyperactivity. These children can be described on a continuum of severity, with the most severe showing behavioral features indistinguishable from conduct disorder. Children with behavioral subtypes of ADHD do not exhibit the specific skill deficits on neuropsychological tests that are characteristic of reading disabled children. There is a second, less prevalent type of cognitive attention-deficit hyperactivity disorder constituting approximately 20% of ADHD children that includes severe academic underachievement along with inattention, impulsivity, and overactivity. Children with the cognitive subtype exhibit information processing deficits that involve inadequate encoding and retrieval of linguistic information, characteristic of reading disabilities.

Entities:  

Mesh:

Year:  1989        PMID: 2793802     DOI: 10.1097/00004583-198909000-00016

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  17 in total

1.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

2.  The worldwide prevalence of ADHD: is it an American condition?

Authors:  Stephen V Faraone; Joseph Sergeant; Christopher Gillberg; Joseph Biederman
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

3.  Error-related event-related potentials in children with attention-deficit hyperactivity disorder, oppositional defiant disorder, reading disorder, and math disorder.

Authors:  Andrea Burgio-Murphy; Rafael Klorman; Sally E Shaywitz; Jack M Fletcher; Karen E Marchione; John Holahan; Karla K Stuebing; Joan E Thatcher; Bennett A Shaywitz
Journal:  Biol Psychol       Date:  2006-12-17       Impact factor: 3.251

4.  Are motor inhibition and cognitive flexibility dead ends in ADHD?

Authors:  Nanda N J Rommelse; Marieke E Altink; Leo M J de Sonneville; Cathelijne J M Buschgens; Jan Buitelaar; Jaap Oosterlaan; Joseph A Sergeant
Journal:  J Abnorm Child Psychol       Date:  2007-05-15

5.  Memory processes in learning disability subtypes of children born preterm.

Authors:  Thomasin E McCoy; Amy L Conrad; Lynn C Richman; Peg C Nopoulos; Edward F Bell
Journal:  Child Neuropsychol       Date:  2012-03-01       Impact factor: 2.500

6.  A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11.

Authors:  Matthew N Ogdie; I Laurence Macphie; Sonia L Minassian; May Yang; Simon E Fisher; Clyde Francks; Rita M Cantor; James T McCracken; James J McGough; Stanley F Nelson; Anthony P Monaco; Susan L Smalley
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

7.  Language abilities in children with attention deficit hyperactivity disorder, reading disabilities, and normal controls.

Authors:  K L Purvis; R Tannock
Journal:  J Abnorm Child Psychol       Date:  1997-04

8.  The utility of curriculum-based measurement for evaluating the effects of methylphenidate on academic performance.

Authors:  G Stoner; S P Carey; M J Ikeda; M R Shinn
Journal:  J Appl Behav Anal       Date:  1994

9.  On the differential diagnosis of reading, attentional and depressive disorders.

Authors:  J Cohen
Journal:  Ann Dyslexia       Date:  1994-01

10.  Attention deficits: current concepts, controversies, management, and approaches to classroom instruction.

Authors:  B Busch
Journal:  Ann Dyslexia       Date:  1993-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.